You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.
Ranitidine

Ranitidine Injection 50 mg contains the active substance Ranitidine, one of a group of medicines called H2-antagonists, that reduces the amount of excess acid made by your stomach. It is used in people who are hospitalized to treat certain conditions in which the stomach produces too much acid. Ranitidine 50 mg injection is also used to treat ulcers (sores in the lining of the stomach or intestine) which did not get cured with other medications. This medicine should relieve indigestion and heartburn within a few hours. Ranitidine injection is used in some hospitalized patients with pathological hypersecretory conditions or intractable duodenal ulcers or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication. It is given in cases where oral administration is not possible.

  • Composition

    Ranitidine Hydrochloride 2 mg

  • Release form

    Injection

  • Category

    Antagonists

Indications

Indicated for the treatment of duodenal ulcer, benign gastric ulcer, post-operative ulcer, and of Zollinger - Ellison Syndrome. (In the management of conditions where reduction of gastric secretion and acid output is desirable, such as reflux esophagitis).

Pharmacology

Ranitidine hydrochloride is a competitive, reversible inhibitor of the action of histamine at the histamine H2-receptors, including receptors on the gastric cells. Ranitidine hydrochloride does not lower serum Ca++ in hypercalcemic states. This reduces the amount of acid in the stomach. The drug starts to work in as little as 30 minutes. It can control acid production for up to 12 hours and reduce the frequency and severity of heartburn.

Precautions & Warnings

If you are pregnant, trying to become pregnant, or are breastfeeding, ask your doctor or nurse for advice before being given Tranexamic Acid injection. Keep out of reach of the children